Navigation Links
After the yeast is gone bacteria continue to develop flavor of sparkling wine

Researchers at the University of Barcelona, Spain, show for the first time that bacteria, in addition to yeast, are involved in the secondary fermentation of the sparkling wine known as Cava. They report their findings today at the 105th General Meeting of the American Society for Microbiology.

"Bacteria found in Cava samples could have a distinctive impact upon sparkling wine quality in terms of aroma, flavor, bubble size and bubble persistence, especially for premium quality wines," says NĂºria Rius, a researcher on the study.

The traditional Champenoise method of sparkling wine production requires addition of sucrose and yeast strains to the base wine for a second fermentation in the bottle in which the wine is sold. The secondary fermentation produces carbon dioxide which dissolves in the wine and is perceived as bubbles when the bottle is opened, hence the term "sparkling". After the fermentation is completed the Cava wine is aged in the bottles with the yeast for at least nine months, or longer for premium quality wines. During aging, substantial chemical changes take place due to cell lysis which contributes to the sensory characteristics of Cava.

The researchers isolated 617 microbial strains from two Cavas, after 9 to 17 months of bottling. No yeasts were isolated after 10 months of bottling. Gram-negative and Gram-positive bacteria were isolated from both wines. Different phases of the aging process are dominated by different bacteria. Gram-negative bacteria were quickly replaced by Gram-positive bacteria, and after 17 months only Gram-positive bacteria were detected in both sparkling wines.

"The products released by the yeast cells affect wine flavor and serve as nutrients for the growth of bacteria. Although yeasts have the dominating influence on the chemical composition of wine, some changes which influence the sensory quality and consumer acceptability of the wine could be due to growth and lysis of bacteria," says Rius.< /p>
'"/>

Source:American Society for Microbiology


Related biology news :

1. Bone Density Recovers After Teens Stop Injected Contraceptive
2. Youth With HIV Take More Risks After New Meds Introduced
3. After a time-shift, mixed signals from the circadian clock
4. Drug Offers Alternative to Surgical Treatment After Miscarriage
5. Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy
6. Researchers Find Drug May Give Some Cardiac Protection 24 Hours After Heart Attack
7. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
8. Navigating an integrated yeast network
9. GlycoFi announces the first production of antibodies with human glycosylation in yeast
10. From a lowly yeast, researchers divine a clue to human disease
11. GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology: